About Delphinus Medical Technologies
Delphinus Medical Technologies is a company based in Plymouth (United States) founded in 2010 by Neb Duric.. Delphinus Medical Technologies has raised $136.54 million across 14 funding rounds from investors including HHS, GE Capital and Trinity Cap. Delphinus Medical Technologies offers products and services including SoftVue. Delphinus Medical Technologies operates in a competitive market with competitors including CairnSurgical, Oncovision, Niramai, QT Imaging and Olive Healthcare, among others.
- Headquarter Plymouth, United States
- Founders Neb Duric
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Delphinus Medical Technologies
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$136.54 M (USD)
in 14 rounds
-
Latest Funding Round
$27.6 M (USD), Series D
Mar 22, 2024
-
Investors
HHS
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Delphinus Medical Technologies
Delphinus Medical Technologies offers a comprehensive portfolio of products and services, including SoftVue. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers 3D tomography for detecting breast cancer in dense tissues.
Unlock access to complete
Funding Insights of Delphinus Medical Technologies
Delphinus Medical Technologies has successfully raised a total of $136.54M across 14 strategic funding rounds. The most recent funding activity was a Series D round of $27.6 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series D — $27.6M
- First Round First Round
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series D - Delphinus Medical Technologies | Valuation |
investors |
|
| Aug, 2023 | Amount | Debt – Venture - Delphinus Medical Technologies | Valuation |
investors |
|
| Jun, 2023 | Amount | Series D - Delphinus Medical Technologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Delphinus Medical Technologies
Delphinus Medical Technologies has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, GE Capital and Trinity Cap. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt and equipment financing are provided to growth-stage companies.
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location | |
|
Investments are made in growth-stage startups by Beringea.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Delphinus Medical Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Delphinus Medical Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Delphinus Medical Technologies Comparisons
Competitors of Delphinus Medical Technologies
Delphinus Medical Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CairnSurgical, Oncovision, Niramai, QT Imaging and Olive Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of 3D printed surgical guides for breast cancer treatment
|
|
| domain | founded_year | HQ Location |
Diagnostic imaging devices for oncology are manufactured and provided.
|
|
| domain | founded_year | HQ Location |
Early breast cancer is detected using AI-based non-invasive thermal imaging.
|
|
| domain | founded_year | HQ Location |
Non-invasive ultrasound device for breast cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Devices and software for wellness and medical uses are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Delphinus Medical Technologies
Frequently Asked Questions about Delphinus Medical Technologies
When was Delphinus Medical Technologies founded?
Delphinus Medical Technologies was founded in 2010.
Where is Delphinus Medical Technologies located?
Delphinus Medical Technologies is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Who is the current CEO of Delphinus Medical Technologies?
Scott A White is the current CEO of Delphinus Medical Technologies.
Is Delphinus Medical Technologies a funded company?
Delphinus Medical Technologies is a funded company, having raised a total of $136.54M across 14 funding rounds to date. The company's 1st funding round was a Series D of $5M, raised on May 01, 2010.
What does Delphinus Medical Technologies do?
Delphinus Medical Technologies has designed and developed SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines womens breasts for the presence of benign andor malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. Sound and water are the basis of its technology, where acoustic signals resonating within breast tissue yield a unique signature that it measures. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Who are the top competitors of Delphinus Medical Technologies?
Delphinus Medical Technologies's top competitors include QT Imaging, CairnSurgical and Niramai.
What products or services does Delphinus Medical Technologies offer?
Delphinus Medical Technologies offers SoftVue.
Who are Delphinus Medical Technologies's investors?
Delphinus Medical Technologies has 11 investors. Key investors include HHS, GE Capital, Trinity Cap, Arboretum Ventures, and Beringea.